Stock 2
AstraZeneca
AZN
🇬🇧 United Kingdom💊 Pharmaceuticals🧬 Biotech
Market Cap
$325.05B
$213.34B
Country
United States
United Kingdom
Employees
50000.0
89900.0
Industry
🇺🇸 United States
🇬🇧 United Kingdom
Outstanding Shares
N/A
N/A
Comparison Verdict
About AbbVie and AstraZeneca
AbbVie (ABBV) and AstraZeneca (AZN) are both prominent companies in their respective sectors. This comparison helps investors understand the key differences between these two stocks.
Key Takeaways
- Market Cap: AbbVie ($325.05B) vs AstraZeneca ($213.34B)
- Valuation: AbbVie has a P/E ratio of $75.51 vs $30.24 for AstraZeneca
- Dividend Yield: AbbVie offers 3.49% vs 2.26% from AstraZeneca
- Assets: AbbVie has $135.16B in total assets compared to $104.03B for AstraZeneca
- 1-Year Performance: AbbVie gained 1.84% vs gain of 0.69% for AstraZeneca